generative-virtual-screening

The NVIDIA BioNeMo blueprint provides a framework for generative virtual screening in drug discovery, utilizing advanced AI models to design and optimize small molecules and predict protein-ligand interactions. It integrates various tools for protein structure prediction and molecular generation, facilitating efficient drug discovery workflows.